CXCL8 and lung carcinoma: (2017) have demonstrated that the molecule ZO‐1, located at the membrane in epithelial cells but transported into the nuclear/cytoplasmic compartment upon EMT‐associated junction disruption, activates the secretion of IL‐8 via the NF‐kB pathway in breast and lung cancer cell lines.